Roy Freeman
Director/Miembro de la Junta en INHIBIKASE THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Cargos activos de Roy Freeman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Miembro de la Junta | 22/12/2020 | - |
| Independent Dir/Board Member | 22/12/2020 | - | |
| Harvard Medical School | Corporate Officer/Principal | - | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Cnd Life Sciences, Inc.
 Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Director/Miembro de la Junta | - | - |
| Fundador | - | - |
Historial de carrera de Roy Freeman
Antiguos cargos conocidos de Roy Freeman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
World Federation of Neurology
 World Federation of Neurology Miscellaneous Commercial ServicesCommercial Services World Federation of Neurology operates as an association of national neurological societies. The firm promotes neurology worldwide, and to improve prevention and diagnosis management for patients. The company was founded in 1957 and is headquartered in Richmond, the United Kinmgdom. | Presidente | - | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - | - |
| American Autonomic Society | Presidente | - | - |
Neurobo Therapeutics, Inc.
 Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Director/Miembro de la Junta | - | - |
| Fundador | - | - |
Formación de Roy Freeman.
| University of Cape Town | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Sudafrica | 2 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Founder | 2 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Neurobo Therapeutics, Inc.
Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Commercial Services |
| American Autonomic Society | |
World Federation of Neurology
World Federation of Neurology Miscellaneous Commercial ServicesCommercial Services World Federation of Neurology operates as an association of national neurological societies. The firm promotes neurology worldwide, and to improve prevention and diagnosis management for patients. The company was founded in 1957 and is headquartered in Richmond, the United Kinmgdom. | Commercial Services |
Cnd Life Sciences, Inc.
Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Health Services |
- Bolsa de valores
- Insiders
- Roy Freeman
- Experiencia
